WeGreened Approval Statistics: Week of July 7, 2025

WeGreened Weekly Approval Summary

Week of July 7–13, 2025

During this week, WeGreened received a total of 93 approval notices from the United States Citizenship and Immigration Services (USCIS). The EB-2 NIW (National Interest Waiver) remained the leading category, making up 70% of approvals. Meanwhile, EB-1A (Alien of Extraordinary Ability) maintained steady performance and continued to attract high-level scientific research professionals.

Approval Distribution by Category and Service Center

Of the 93 approvals, 65 were for NIW, 22 for EB1A, 2 for EB1B (Outstanding Professors or Researchers), and 4 for O1A (Individuals with Extraordinary Ability or Achievement). The Nebraska Service Center processed 14 EB1A and 34 NIW approvals, while the Texas Service Center handled 7 EB1A and 30 NIW. One EB1A and one NIW case were transferred from NSC to TSC.

Academic Output Quartiles

For the 22 EB1A approvals, the number of published articles ranged from 6 to 55, with the first quartile at 12.25, median at 18, and third quartile at 26.5. Citations ranged from 128 to 3,798, with quartiles at 349 (Q1), 551 (median), and 1,144 (Q3).
In contrast, the 65 NIW cases had publication counts ranging from 1 to 51 articles. The quartiles stood at 6, 9, and 15 respectively. Citation counts ranged from 15 to 7,000, with Q1 at 62, median at 150, and Q3 at 262.

While EB1A petitioners typically exhibit higher density in academic publications and citations, NIW applicants often showcase stronger interdisciplinary skills and practical technical contributions. Both categories continue to demonstrate broad eligibility across various research and application domains.

Applicant Backgrounds and Research Areas

EB1A applicants tend to specialize in fields such as biomedical engineering, electronic materials, neuroscience, and artificial intelligence optimization. Many come from postdoctoral or senior industrial research backgrounds, with a strong presence in international publishing and peer review activities. These profiles often clearly align with the “top percentile” expectation in their disciplines.

NIW applicants are frequently engaged in public health, agricultural biotechnology, energy engineering, social policy, or structural design. Their backgrounds vary from doctoral students and R&D engineers to policy researchers. These cases typically emphasize how their work directly impacts American society, economy, and policy advancement.

Case Study: Low-Citation NIW Approval

One notable case involved an NIW applicant in the field of quantitative finance, with only three published articles and 15 citations. Holding a Ph.D. and filing through NSC, the applicant focused on optimizing market modeling and investment decision algorithms. Despite limited academic output, their research’s potential contributions to financial stability and regulatory applications were recognized by the immigration officer, leading to a successful approval. This case highlights NIW’s receptiveness to practical, cross-disciplinary research profiles.

Policy and Review Trends

For EB1A, officers continue to focus on international recognition, measurable field influence, and indicators such as publications, citations, peer review roles, awards, and leadership. Applicants must demonstrate excellence from multiple angles.

In the NIW category, evaluators pay closer attention to whether the applicant’s work aligns with the broader social, economic, and policy priorities of the United States. The flexibility in review standards for interdisciplinary and practice-oriented researchers makes NIW especially suitable for early-career scholars and applied experts.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.